Ocular iontophoretic supplementation of intravenous foscarnet therapy

American Journal of Ophthalmology

Volumn 122, Issue 1, 1996, Pages 86-90

  Yoshizumi, M O ^a   Roca, J A ^a   Lee, D A ^a   Lee, G ^a   Gomez, I ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; RETINITIS; VITREOUS BODY;

EID: 0029901706     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)71967-1     Document Type: Article

References (23)

1. Holland GN Pepose JS Pettit TH Gottlieb MS Yee RD Foos RY Acquired immune deficiency syndrome: ocular manifestations Ophthalmology 90 1983 859 873
2. Freeman WR Lerner CW Mines JA Lash RS Nadel AJ Starr MB A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome Am J Ophthalmol 97 1984 133 142
3. Pepose JS Holland GN Nestor MS Cochran AJ Foos RY Acquired immune deficiency syndrome: pathogenic mechanisms of ocular disease Ophthalmology 92 1985 472 484
4. Jabs DA Green WR Fox R Polk BF Bartlett JG Ocular manifestations of acquired immune deficiency syndrome Ophthalmology 96 1989 1092 1099
5. Pertel P Hirschtick R Phair J Chmiel J Poggensee L Murphy R Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus J Acquir Immune Defic Syndr 5 1992 1069 1074
6. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, et al, for the Multicenter AIDS Cohort Study. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993;329:1922–6
7. Jacobson MA O'Donnell JJ Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet J Acquir Immune Defic Syndr 4 1991 S11 S15 (Suppl 1)
8. Jabs DA Newman C de Bustros S Polk BF Treatment of cytomegalovirus retinitis with ganciclovir Ophthalmology 94 1987 824 830
9. LeHoang P Girard B Robinet M Marcel P Zazoun L Matheron S Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome Ophthalmology 96 1989 865 874
10. Palestine AG Polis MA De Smet MD Baird BF Falloon J Kovacs JA A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS Ann Intern Med 115 1991 665 673
11. Studies of Ocular Complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG). Studies of ocular complications of AIDS foscarnet-ganciclovir cytomegalovirus retinitis trial: 1. Rationale, design, and methods. Control Clin Trials 1992;13:22–39
12. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992;326:213–20
13. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial: 4. Visual outcomes. Ophthalmology 1994;101:1250–61
14. Heinemann MH Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy Arch Ophthalmol 107 1989 1767 1772
15. Díaz-Llopis M Chipont E Sanchez S España E Navea A Menezo JL Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome Am J Ophthalmol 114 1992 742 747
16. Sanborn GE Anand R Torti RE Nightingale SD Cal SX Yates B Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis: use of an intravitreal device Arch Ophthalmol 110 1992 188 195
17. Yoshizumi MO Lee D Vinci V Fajardo S Ocular toxicity of multiple intravitreal DHPG injections Graefes Arch Clin Exp Ophthalmol 228 1990 350 355
18. Kreiger AE Foos RY Yoshizumi MO Intravitreous granulation tissue and retinal detachment following pars plana injection for cytomegalovirus retinopathy Graefes Arch Clin Exp Ophthalmol 230 1992 197 198
19. Anand R Nightingale SD Fish RH Smith TJ Ashton P Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir Arch Ophthalmol 111 1993 223 227
20. Smith TJ Pearson PA Blandford DL Brown JD Coins KA Hollins JL Intravitreal sustained-release ganciclovir Arch Ophthalmol 110 1992 255 258
21. Sarraf D Equi RA Holland GN Yoshizumi MO Lee DA Transscleral iontophoresis of foscarnet Am J Ophthalmol 115 1993 748 754
22. Pettersson KJ Nordgren T Westerlund D Determination of phosphonoformate (foscarnet) in biological fluids by ion-pair reversed-phase liquid chromatography J Chromatogr 488 1989 447 455
23. Kuppermann BD Quiceno JI Flores-Aguilar M Connor JD Capparelli EV Sherwood CH Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy J Infect Dis 168 1993 1506 1509